Excalibur Management Corp lessened its holdings in JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 0.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 37,739 shares of the financial services provider’s stock after selling 87 shares during the period. JPMorgan Chase & Co. comprises approximately 2.5% of Excalibur Management Corp’s holdings, making the stock its 8th biggest holding. Excalibur Management Corp’s holdings in JPMorgan Chase & Co. were worth $4,918,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in JPM. Adirondack Retirement Specialists Inc. increased its stake in JPMorgan Chase & Co. by 510.8% during the 1st quarter. Adirondack Retirement Specialists Inc. now owns 226 shares of the financial services provider’s stock worth $29,000 after buying an additional 189 shares during the period. Nordwand Advisors LLC purchased a new stake in shares of JPMorgan Chase & Co. during the first quarter worth about $30,000. Boulder Wealth Advisors LLC acquired a new position in shares of JPMorgan Chase & Co. in the fourth quarter worth about $43,000. Capital Directions Investment Advisors LLC purchased a new position in JPMorgan Chase & Co. in the fourth quarter valued at about $44,000. Finally, VitalStone Financial LLC acquired a new stake in JPMorgan Chase & Co. during the 4th quarter valued at approximately $58,000. Institutional investors and hedge funds own 70.10% of the company’s stock.
JPMorgan Chase & Co. Trading Down 1.3 %
JPMorgan Chase & Co. stock opened at $153.79 on Thursday. JPMorgan Chase & Co. has a 52-week low of $101.28 and a 52-week high of $159.38. The company has a quick ratio of 0.90, a current ratio of 0.90 and a debt-to-equity ratio of 1.28. The firm has a market capitalization of $446.93 billion, a price-to-earnings ratio of 9.90, a PEG ratio of 2.06 and a beta of 1.10. The firm has a 50-day moving average price of $147.49 and a two-hundred day moving average price of $140.24.
JPMorgan Chase & Co. Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, July 31st. Stockholders of record on Thursday, July 6th were given a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a dividend yield of 2.60%. The ex-dividend date was Wednesday, July 5th. JPMorgan Chase & Co.’s dividend payout ratio (DPR) is presently 25.74%.
Insider Transactions at JPMorgan Chase & Co.
In related news, insider Ashley Bacon sold 16,766 shares of JPMorgan Chase & Co. stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $135.00, for a total transaction of $2,263,410.00. Following the transaction, the insider now directly owns 195,356 shares of the company’s stock, valued at $26,373,060. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, General Counsel Stacey Friedman sold 4,310 shares of JPMorgan Chase & Co. stock in a transaction on Monday, August 7th. The stock was sold at an average price of $157.16, for a total transaction of $677,359.60. Following the transaction, the general counsel now owns 57,735 shares in the company, valued at $9,073,632.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ashley Bacon sold 16,766 shares of the company’s stock in a transaction on Monday, May 15th. The shares were sold at an average price of $135.00, for a total value of $2,263,410.00. Following the transaction, the insider now directly owns 195,356 shares in the company, valued at $26,373,060. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 36,531 shares of company stock valued at $5,088,550. Corporate insiders own 0.79% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have recently commented on JPM. Barclays increased their target price on JPMorgan Chase & Co. from $179.00 to $182.00 in a research note on Sunday, July 16th. Odeon Capital Group upgraded shares of JPMorgan Chase & Co. from a “hold” rating to a “buy” rating in a research note on Monday, May 1st. Credit Suisse Group upped their target price on shares of JPMorgan Chase & Co. from $160.00 to $170.00 in a research note on Monday, July 17th. StockNews.com initiated coverage on JPMorgan Chase & Co. in a research note on Thursday, May 18th. They issued a “hold” rating for the company. Finally, 888 restated a “maintains” rating on shares of JPMorgan Chase & Co. in a research note on Monday, June 26th. Seven equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, JPMorgan Chase & Co. currently has a consensus rating of “Moderate Buy” and a consensus target price of $164.39.
Get Our Latest Research Report on JPMorgan Chase & Co.
About JPMorgan Chase & Co.
JPMorgan Chase & Co operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services to consumers and small businesses; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services.
Featured Articles
- Five stocks we like better than JPMorgan Chase & Co.
- The How And Why of Investing in Oil Stocks
- 3 Best Renewable Energy Stocks as Summer Heat Builds
- What is the S&P/TSX Index?
- Kinder Morgan Shines With Dividend Yield, Cash Flow, Buybacks
- What Does Downgrade Mean in Investing?
- 3 Stocks to Buy No Matter Which Way Inflation Moves
Receive News & Ratings for JPMorgan Chase & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase & Co. and related companies with MarketBeat.com's FREE daily email newsletter.
